Is it time to screen all patients with hypertension for primary aldosteronism? Screening for primary aldosteronism in patients newly diagnosed with hypertension would maximise treatment benefits and minimise end-organ damage

Jun Yang, Peter J Fuller, Michael Stowasser

Research output: Contribution to journalArticleOtherpeer-review

Original languageEnglish
Pages (from-to)57-59.e1
Number of pages4
JournalMedical Journal of Australia
Volume209
Issue number2
DOIs
Publication statusPublished - 16 Jul 2018

Cite this

@article{20a6197662da468992a1d0b502083804,
title = "Is it time to screen all patients with hypertension for primary aldosteronism? Screening for primary aldosteronism in patients newly diagnosed with hypertension would maximise treatment benefits and minimise end-organ damage",
author = "Jun Yang and Fuller, {Peter J} and Michael Stowasser",
year = "2018",
month = "7",
day = "16",
doi = "10.5694/mja17.00783",
language = "English",
volume = "209",
pages = "57--59.e1",
journal = "Medical Journal of Australia",
issn = "0025-729X",
publisher = "AMPCo",
number = "2",

}

TY - JOUR

T1 - Is it time to screen all patients with hypertension for primary aldosteronism? Screening for primary aldosteronism in patients newly diagnosed with hypertension would maximise treatment benefits and minimise end-organ damage

AU - Yang, Jun

AU - Fuller, Peter J

AU - Stowasser, Michael

PY - 2018/7/16

Y1 - 2018/7/16

UR - http://www.scopus.com/inward/record.url?scp=85060310292&partnerID=8YFLogxK

U2 - 10.5694/mja17.00783

DO - 10.5694/mja17.00783

M3 - Article

VL - 209

SP - 57-59.e1

JO - Medical Journal of Australia

JF - Medical Journal of Australia

SN - 0025-729X

IS - 2

ER -